'Tacrolimus' presentation slideshows

Diagnosis of Death Masterclass

1.77k views • 147 slides

Kidney Transplantation

Kidney Transplantation. Best treatment of chronic renal failure. HEMODIALYSIS. PERITONEAL DIALYSIS. Renal transplantation needs donor kidney. Organ Source. Cadaver Living donor. Yaln?z kalp atacak. HLA TYPING. HLA ANTIGENS A B C DR LOCUS

868 views • 54 slides

Clinical Case Conference

Clinical Case Conference. November 30 th , 2011 Allen Hwang, MD. HPI. 30 y/o M with h/o cystic fibrosis c/b multiple pneumonias, chronic sinusitis, pancreatic insufficiency, failure to thrive, chronic O2 requirement s/p bilateral lung transplant June, 2010 (CMV D-/R-). HPI.

590 views • 39 slides

Strategies for Maximizing Outcomes in Liver Transplantation

Strategies for Maximizing Outcomes in Liver Transplantation. James D. Eason, M.D. Chief of Transplantation / Professor of Surgery University of Tennessee / Methodist Transplant Institute. Recent Publications.

463 views • 24 slides

Topical Immunosuppressants

Topical Immunosuppressants. Bindi M. Nikhar, M.D., FAAP Division of Dermatologic and Dental Drug Products, ODE V. TOPICAL IMMUNOSUPPRESSANTS. Newest pharmacological class for AD Introduced in this decade Direct immunosuppressive action in diseases with an immunological basis

447 views • 24 slides

Systemic Exposure of Topical Tacrolimus

Systemic Exposure of Topical Tacrolimus. Veneeta Tandon, Ph.D. Pharmacokinetics Reviewer Division of Pharmaceutical Evaluation III Office of Clinical Pharmacology and Biopharmaceutics. Adult PK Studies In NDA. In healthy volunteers (N=12)

254 views • 13 slides

Global Tacrolimus Industry Product Classification & Gross Ma

169 views • 5 slides

Tacrolimus Market Growth Analysis and Forecasts to 2026

Advancement in organ transplant procedures is a major factor expected to increase the number of organ transplants, which in turn is expected to boost market growth.

45 views • 4 slides

Tacrolimus Market Effect and Growth Factors Research and Projection Till 2026

Tacrolimus is used as an immunosuppressant mainly after organ transplant procedures to prevent organ rejection.

42 views • 4 slides

Tacrolimus Market Effect and Growth Factors Research and Projection Till 2026

Tacrolimus is used as an immunosuppressant mainly after organ transplant procedures to prevent organ rejection.

40 views • 4 slides

Supplemental Diglta Content 1 _ Figure 1

Supplemental Diglta Content 1 _ Figure 1. Effector T cells (Th-). a/. Regulatory T cells. Treg. Th17. Th1. Th2. GATA3. FOXP3. ROR g t. Tbet. ns. ns. ns. *. ns. ns. ***. ***. ***. ***. ***. **. IFN g. IL17A. IL4. TGF b. ns. ns. ns. **. ns. ***. ***. ***. ns.

102 views • 3 slides